Michael Comstock

Davis Polk advised REV Group, Inc. on its $275 million initial public offering of 12,500,000 shares of common stock. The shares of common stock are listed on the New York Stock Exchange…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Tech Data Corporation of $500 million aggregate principal amount of its 3.700% senior…

Davis Polk advised the sole underwriter in connection with a $201.25 million SEC-registered offering of 3,220,000 shares of common stock of Pinnacle Financial Partners, Inc. Included…

Davis Polk advised the joint book-running managers in connection with the approximately $237 million primary offering of 10,000,000 shares of common stock of Summit Materials, Inc. The…

Davis Polk advised Freeport-McMoRan Inc. (the “Company”) in connection with its offer to exchange any and all of the 6.125% senior notes due 2019, 6.50% senior notes due 2020, 6.625% senior…

Davis Polk advised the sole bookrunning manager in a Rule 144A/Regulation S offering by Nuance Communications, Inc. of $500 million aggregate principal amount of its 5.625% senior notes due…

Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 40,000,000 shares of common stock of Callon Petroleum Company. The shares are…

Davis Polk advised the joint book-running managers in connection with the offering of 4,000,000 shares of Class A common stock of Genesee & Wyoming Inc. The net proceeds from the Class…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of 8,050,000 depositary shares of Rexnord Corporation, each representing a 1…

Davis Polk is advising Roche Holding Ltd. in connection with the sale of an active pharmaceutical ingredients manufacturing facility in Florence, South Carolina, to Patheon N.V. Under the…